Supplementary Figure 1 from Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity Article Swipe

View

Robert M. Campbell , Bryan D. Anderson , Nathan A. Brooks , Harold B. Brooks , Edward M. Chan , Alfonso de Dios , Raymond Gilmour , Jeremy R. Graff , Enrique Jambrina , Mary M. Mader , Denis McCann , Songqing Na , Stephen H. Parsons , Susan E. Pratt , Chuan Shih , Louis F. Stancato , James J. Starling , Courtney M. Tate , Juan A. Velasco , Yong Wang , Xiang S. Ye ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1535-7163.22500817.v1

PDF file - 43K, Effect of LY2228820 on MK2 phosphorylation in mouse peripheral blood mononuclear cells (PBMC) and from patients with multiple myeloma.

Related Topics

Concepts

Peripheral blood mononuclear cell Phosphorylation Peripheral blood p38 mitogen-activated protein kinases Chemistry Multiple myeloma MAPK/ERK pathway Cancer research Pharmacology Molecular biology In vitro Medicine Internal medicine Biology Biochemistry

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1535-7163.22500817.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4362621538

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4362621538

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1535-7163.22500817.v1

Digital Object Identifier
Title: Supplementary Figure 1 from Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-04-03

Full publication date if available
Authors: Robert M. Campbell, Bryan D. Anderson, Nathan A. Brooks, Harold B. Brooks, Edward M. Chan, Alfonso de Dios, Raymond Gilmour, Jeremy R. Graff, Enrique Jambrina, Mary M. Mader, Denis McCann, Songqing Na, Stephen H. Parsons, Susan E. Pratt, Chuan Shih, Louis F. Stancato, James J. Starling, Courtney M. Tate, Juan A. Velasco, Yong Wang, Xiang S. Ye

List of authors in order
Landing page: https://doi.org/10.1158/1535-7163.22500817.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1535-7163.22500817.v1

Direct OA link when available
Concepts: Peripheral blood mononuclear cell, Phosphorylation, Peripheral blood, p38 mitogen-activated protein kinases, Chemistry, Multiple myeloma, MAPK/ERK pathway, Cancer research, Pharmacology, Molecular biology, In vitro, Medicine, Internal medicine, Biology, Biochemistry

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4362621538
doi	https://doi.org/10.1158/1535-7163.22500817.v1
ids.doi	https://doi.org/10.1158/1535-7163.22500817.v1
ids.openalex	https://openalex.org/W4362621538
fwci	0.0
type	preprint
title	Supplementary Figure 1 from Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11533
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9945999979972839
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1312
topics[0].subfield.display_name	Molecular Biology
topics[0].display_name	Melanoma and MAPK Pathways
topics[1].id	https://openalex.org/T10274
topics[1].field.id	https://openalex.org/fields/16
topics[1].field.display_name	Chemistry
topics[1].score	0.9690999984741211
topics[1].domain.id	https://openalex.org/domains/3
topics[1].domain.display_name	Physical Sciences
topics[1].subfield.id	https://openalex.org/subfields/1605
topics[1].subfield.display_name	Organic Chemistry
topics[1].display_name	Synthesis and biological activity
topics[2].id	https://openalex.org/T13779
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9538000226020813
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2734
topics[2].subfield.display_name	Pathology and Forensic Medicine
topics[2].display_name	Cancer Mechanisms and Therapy
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C137061746
concepts[0].level	3
concepts[0].score	0.8341437578201294
concepts[0].wikidata	https://www.wikidata.org/wiki/Q736033
concepts[0].display_name	Peripheral blood mononuclear cell
concepts[1].id	https://openalex.org/C11960822
concepts[1].level	2
concepts[1].score	0.56212317943573
concepts[1].wikidata	https://www.wikidata.org/wiki/Q242736
concepts[1].display_name	Phosphorylation
concepts[2].id	https://openalex.org/C3017910909
concepts[2].level	2
concepts[2].score	0.533941924571991
concepts[2].wikidata	https://www.wikidata.org/wiki/Q618363
concepts[2].display_name	Peripheral blood
concepts[3].id	https://openalex.org/C51551487
concepts[3].level	4
concepts[3].score	0.5187440514564514
concepts[3].wikidata	https://www.wikidata.org/wiki/Q2043632
concepts[3].display_name	p38 mitogen-activated protein kinases
concepts[4].id	https://openalex.org/C185592680
concepts[4].level	0
concepts[4].score	0.48065364360809326
concepts[4].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[4].display_name	Chemistry
concepts[5].id	https://openalex.org/C2776364478
concepts[5].level	2
concepts[5].score	0.44093164801597595
concepts[5].wikidata	https://www.wikidata.org/wiki/Q467635
concepts[5].display_name	Multiple myeloma
concepts[6].id	https://openalex.org/C57074206
concepts[6].level	3
concepts[6].score	0.4290686249732971
concepts[6].wikidata	https://www.wikidata.org/wiki/Q14197552
concepts[6].display_name	MAPK/ERK pathway
concepts[7].id	https://openalex.org/C502942594
concepts[7].level	1
concepts[7].score	0.39865171909332275
concepts[7].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[7].display_name	Cancer research
concepts[8].id	https://openalex.org/C98274493
concepts[8].level	1
concepts[8].score	0.3944043517112732
concepts[8].wikidata	https://www.wikidata.org/wiki/Q128406
concepts[8].display_name	Pharmacology
concepts[9].id	https://openalex.org/C153911025
concepts[9].level	1
concepts[9].score	0.3900691866874695
concepts[9].wikidata	https://www.wikidata.org/wiki/Q7202
concepts[9].display_name	Molecular biology
concepts[10].id	https://openalex.org/C202751555
concepts[10].level	2
concepts[10].score	0.3312245011329651
concepts[10].wikidata	https://www.wikidata.org/wiki/Q221681
concepts[10].display_name	In vitro
concepts[11].id	https://openalex.org/C71924100
concepts[11].level	0
concepts[11].score	0.2881700396537781
concepts[11].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[11].display_name	Medicine
concepts[12].id	https://openalex.org/C126322002
concepts[12].level	1
concepts[12].score	0.2797471880912781
concepts[12].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[12].display_name	Internal medicine
concepts[13].id	https://openalex.org/C86803240
concepts[13].level	0
concepts[13].score	0.26314425468444824
concepts[13].wikidata	https://www.wikidata.org/wiki/Q420
concepts[13].display_name	Biology
concepts[14].id	https://openalex.org/C55493867
concepts[14].level	1
concepts[14].score	0.21719172596931458
concepts[14].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[14].display_name	Biochemistry
keywords[0].id	https://openalex.org/keywords/peripheral-blood-mononuclear-cell
keywords[0].score	0.8341437578201294
keywords[0].display_name	Peripheral blood mononuclear cell
keywords[1].id	https://openalex.org/keywords/phosphorylation
keywords[1].score	0.56212317943573
keywords[1].display_name	Phosphorylation
keywords[2].id	https://openalex.org/keywords/peripheral-blood
keywords[2].score	0.533941924571991
keywords[2].display_name	Peripheral blood
keywords[3].id	https://openalex.org/keywords/p38-mitogen-activated-protein-kinases
keywords[3].score	0.5187440514564514
keywords[3].display_name	p38 mitogen-activated protein kinases
keywords[4].id	https://openalex.org/keywords/chemistry
keywords[4].score	0.48065364360809326
keywords[4].display_name	Chemistry
keywords[5].id	https://openalex.org/keywords/multiple-myeloma
keywords[5].score	0.44093164801597595
keywords[5].display_name	Multiple myeloma
keywords[6].id	https://openalex.org/keywords/mapk/erk-pathway
keywords[6].score	0.4290686249732971
keywords[6].display_name	MAPK/ERK pathway
keywords[7].id	https://openalex.org/keywords/cancer-research
keywords[7].score	0.39865171909332275
keywords[7].display_name	Cancer research
keywords[8].id	https://openalex.org/keywords/pharmacology
keywords[8].score	0.3944043517112732
keywords[8].display_name	Pharmacology
keywords[9].id	https://openalex.org/keywords/molecular-biology
keywords[9].score	0.3900691866874695
keywords[9].display_name	Molecular biology
keywords[10].id	https://openalex.org/keywords/in-vitro
keywords[10].score	0.3312245011329651
keywords[10].display_name	In vitro
keywords[11].id	https://openalex.org/keywords/medicine
keywords[11].score	0.2881700396537781
keywords[11].display_name	Medicine
keywords[12].id	https://openalex.org/keywords/internal-medicine
keywords[12].score	0.2797471880912781
keywords[12].display_name	Internal medicine
keywords[13].id	https://openalex.org/keywords/biology
keywords[13].score	0.26314425468444824
keywords[13].display_name	Biology
keywords[14].id	https://openalex.org/keywords/biochemistry
keywords[14].score	0.21719172596931458
keywords[14].display_name	Biochemistry
language	en
locations[0].id	doi:10.1158/1535-7163.22500817.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1535-7163.22500817.v1
locations[1].id	pmh:oai:figshare.com:article/22500817
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Characterization_of_LY2228820_Dimesylate_a_Potent_and_Selective_Inhibitor_of_p38_MAPK_with_Antitumor_Activity/22500817
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5081805141
authorships[0].author.orcid	https://orcid.org/0000-0003-2120-6887
authorships[0].author.display_name	Robert M. Campbell
authorships[0].author_position	first
authorships[0].raw_author_name	Robert M. Campbell
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5001679230
authorships[1].author.orcid
authorships[1].author.display_name	Bryan D. Anderson
authorships[1].author_position	middle
authorships[1].raw_author_name	Bryan D. Anderson
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5062649281
authorships[2].author.orcid	https://orcid.org/0000-0002-5111-6914
authorships[2].author.display_name	Nathan A. Brooks
authorships[2].author_position	middle
authorships[2].raw_author_name	Nathan A. Brooks
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5111871116
authorships[3].author.orcid
authorships[3].author.display_name	Harold B. Brooks
authorships[3].author_position	middle
authorships[3].raw_author_name	Harold B. Brooks
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5083329029
authorships[4].author.orcid	https://orcid.org/0000-0002-1332-2987
authorships[4].author.display_name	Edward M. Chan
authorships[4].author_position	middle
authorships[4].raw_author_name	Edward M. Chan
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5055899487
authorships[5].author.orcid	https://orcid.org/0009-0004-1639-9121
authorships[5].author.display_name	Alfonso de Dios
authorships[5].author_position	middle
authorships[5].raw_author_name	Alfonso De Dios
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5108694174
authorships[6].author.orcid
authorships[6].author.display_name	Raymond Gilmour
authorships[6].author_position	middle
authorships[6].raw_author_name	Raymond Gilmour
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5112264937
authorships[7].author.orcid
authorships[7].author.display_name	Jeremy R. Graff
authorships[7].author_position	middle
authorships[7].raw_author_name	Jeremy R. Graff
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5045631774
authorships[8].author.orcid
authorships[8].author.display_name	Enrique Jambrina
authorships[8].author_position	middle
authorships[8].raw_author_name	Enrique Jambrina
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5108512798
authorships[9].author.orcid
authorships[9].author.display_name	Mary M. Mader
authorships[9].author_position	middle
authorships[9].raw_author_name	Mary Mader
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5044441430
authorships[10].author.orcid
authorships[10].author.display_name	Denis McCann
authorships[10].author_position	middle
authorships[10].raw_author_name	Denis McCann
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5108521249
authorships[11].author.orcid
authorships[11].author.display_name	Songqing Na
authorships[11].author_position	middle
authorships[11].raw_author_name	Songqing Na
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5109965648
authorships[12].author.orcid
authorships[12].author.display_name	Stephen H. Parsons
authorships[12].author_position	middle
authorships[12].raw_author_name	Stephen H. Parsons
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5032715907
authorships[13].author.orcid
authorships[13].author.display_name	Susan E. Pratt
authorships[13].author_position	middle
authorships[13].raw_author_name	Susan E. Pratt
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5113993285
authorships[14].author.orcid
authorships[14].author.display_name	Chuan Shih
authorships[14].author_position	middle
authorships[14].raw_author_name	Chuan Shih
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5032518555
authorships[15].author.orcid	https://orcid.org/0000-0002-6242-5771
authorships[15].author.display_name	Louis F. Stancato
authorships[15].author_position	middle
authorships[15].raw_author_name	Louis F. Stancato
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5108363588
authorships[16].author.orcid
authorships[16].author.display_name	James J. Starling
authorships[16].author_position	middle
authorships[16].raw_author_name	James J. Starling
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5044326304
authorships[17].author.orcid
authorships[17].author.display_name	Courtney M. Tate
authorships[17].author_position	middle
authorships[17].raw_author_name	Courtney Tate
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5075350338
authorships[18].author.orcid
authorships[18].author.display_name	Juan A. Velasco
authorships[18].author_position	middle
authorships[18].raw_author_name	Juan A. Velasco
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5100424546
authorships[19].author.orcid	https://orcid.org/0000-0003-3652-8037
authorships[19].author.display_name	Yong Wang
authorships[19].author_position	middle
authorships[19].raw_author_name	Yong Wang
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5068058778
authorships[20].author.orcid
authorships[20].author.display_name	Xiang S. Ye
authorships[20].author_position	last
authorships[20].raw_author_name	Xiang S. Ye
authorships[20].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1535-7163.22500817.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure 1 from Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11533
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9945999979972839
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1312
primary_topic.subfield.display_name	Molecular Biology
primary_topic.display_name	Melanoma and MAPK Pathways
related_works	https://openalex.org/W2073641733, https://openalex.org/W2318823989, https://openalex.org/W2376209413, https://openalex.org/W2902056154, https://openalex.org/W2366209661, https://openalex.org/W2362993745, https://openalex.org/W2376631516, https://openalex.org/W2056415482, https://openalex.org/W2419118008, https://openalex.org/W2067160292
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1535-7163.22500817.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1535-7163.22500817.v1
primary_location.id	doi:10.1158/1535-7163.22500817.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1535-7163.22500817.v1
publication_date	2023-04-03
publication_year	2023
referenced_works_count	0
abstract_inverted_index.-	2
abstract_inverted_index.in	10
abstract_inverted_index.of	5
abstract_inverted_index.on	7
abstract_inverted_index.MK2	8
abstract_inverted_index.and	17
abstract_inverted_index.43K,	3
abstract_inverted_index.file	1
abstract_inverted_index.from	18
abstract_inverted_index.with	20
abstract_inverted_index.blood	13
abstract_inverted_index.cells	15
abstract_inverted_index.mouse	11
abstract_inverted_index.(PBMC)	16
abstract_inverted_index.Effect	4
abstract_inverted_index.multiple	21
abstract_inverted_index.patients	19
abstract_inverted_index.LY2228820	6
abstract_inverted_index.peripheral	12
abstract_inverted_index.mononuclear	14
abstract_inverted_index.<p>PDF	0
abstract_inverted_index.phosphorylation	9
abstract_inverted_index.myeloma.</p>	22
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	21
citation_normalized_percentile.value	0.20890085
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False